Business
Currency:USD
2024/Q2
Stock NameRevenueRatio
TRIKAFTA/KAFTRIO2.45B92.58%
Other cystic fibrosis (CF) products196.4M7.42%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States6.04B61.20%
Europe3.11B31.50%
Other719.8M7.29%